Korea non-life insurers shoring up solvency capital
August 14 2018 by InsuranceAsia News
-
New Zealand central bank warns Quest Insurance over non-compliance
- November 12
Quest has acknowledged and remedied the breaches of its obligations and is in the process of implementing further risk management measure, RBNZ said.
-
Central Bank of India’s acquisition of stake in Generali JVs gets antitrust approval
- October 16
The Competition Commission of India has cleared the state-owned lender's acquisition of 24.91% equity stake in Future Generali India and a 25.18% equity stake in Future Generali India Life.
-
APAC business insolvencies projected to increase by 3% in 2024: Allianz Trade
- October 16
A gradual easing of monetary policies could offer some relief, but it won’t be a silver bullet for struggling businesses.
-
Central Bank of India wins bid for minority stake in Generali’s Indian JVs
- August 22
The state-owned lender will acquire the stakes held by the insolvent Future Enterprises in the life and P&C businesses majority owned by the Italian insurance giant for a reported US$60.5m.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
